Symbiox Investment & Trading Co. Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
10.20 Cr.
|
P/BV
|
0.32
|
Book Value (Rs.)
|
10.08
|
52 Week High/Low (Rs.)
|
6/2
|
FV/ML
|
10/1
|
P/E(X)
|
49.39
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.07
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 0.07 | 0.05 | 0.04 | 0.00 | 0.01 |
Diluted EPS (Rs.) | 0.07 | 0.05 | 0.04 | 0.00 | 0.01 |
Cash EPS (Rs.) | 0.06 | 0.05 | 0.04 | 0.02 | 0.01 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 10.08 | 10.01 | 9.96 | 9.90 | 9.87 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 10.08 | 10.01 | 9.96 | 9.90 | 9.87 |
Revenue From Operations / Share (Rs.) | 1.25 | 1.27 | 0.33 | 0.66 | 0.33 |
PBDIT / Share (Rs.) | 0.07 | 0.06 | 0.06 | 0.02 | 0.01 |
PBIT / Share (Rs.) | 0.07 | 0.06 | 0.06 | 0.02 | 0.01 |
PBT / Share (Rs.) | 0.07 | 0.06 | 0.05 | 0.02 | 0.01 |
Net Profit / Share (Rs.) | 0.06 | 0.05 | 0.04 | 0.02 | 0.01 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 6.36 | 5.41 | 17.83 | 4.51 | 3.05 |
PBIT Margin (%) | 6.36 | 5.41 | 17.83 | 4.51 | 3.05 |
PBT Margin (%) | 6.34 | 5.41 | 17.82 | 4.51 | 3.05 |
Net Profit Margin (%) | 5.34 | 3.99 | 13.19 | 3.33 | 2.28 |
Return on Networth / Equity (%) | 0.66 | 0.50 | 0.44 | 0.22 | 0.07 |
Return on Capital Employeed (%) | 0.78 | 0.68 | 0.60 | 0.30 | 0.10 |
Return On Assets (%) | 0.65 | 0.48 | 0.43 | 0.20 | 0.07 |
Asset Turnover Ratio (%) | 0.12 | 0.12 | 0.03 | 0.06 | 0.03 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 104.48 | 22.77 | 49.16 | 14.52 | 38.66 |
Quick Ratio (X) | 104.19 | 22.63 | 49.16 | 14.52 | 38.66 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 448.66 | 1238.78 | 1311.53 | 0.00 | 0.00 |
Interest Coverage Ratio (Post Tax) (%) | 377.65 | 914.92 | 970.79 | 0.00 | 0.00 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 8.23 | 10.28 | 15.14 | 2.70 | 0.62 |
EV / Net Operating Revenue (X) | 2.11 | 2.58 | 14.38 | 1.30 | 0.59 |
EV / EBITDA (X) | 33.17 | 47.68 | 80.60 | 28.78 | 19.47 |
MarketCap / Net Operating Revenue (X) | 2.19 | 2.72 | 14.56 | 1.37 | 0.60 |
Price / BV (X) | 0.27 | 0.34 | 0.49 | 0.09 | 0.02 |
Price / Net Operating Revenue (X) | 2.19 | 2.72 | 14.58 | 1.37 | 0.60 |
EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 |